Wegovy Pen Dosage: Starting Dose, Dose Increases, and Maintenance

Wegovy is a once-weekly semaglutide injection pen. The usual FDA-labeled schedule starts at 0.25 mg weekly for 4 weeks, then increases every 4 weeks toward a maintenance dose, commonly 2.4 mg weekly when tolerated. Dose changes should be made only with a licensed prescriber because side effects, contraindications, and eligibility vary 1.

What is the standard Wegovy pen dosage schedule?

Wegovy pen dosage is designed to rise slowly over about 16 weeks before maintenance dosing. The goal is not to rush; gradual titration helps the body adjust to semaglutide’s effects on appetite, gastric emptying, and gut signaling 1.

Wegovy (semaglutide, a GLP-1 receptor agonist; brand-name FDA-approved medication) is prescribed along with reduced-calorie eating and increased physical activity for chronic weight management in eligible adults and some adolescents. Semaglutide has also been studied in large STEP trials in adults with overweight or obesity, where once-weekly semaglutide was associated with weight loss while gastrointestinal side effects were common; individual results vary 2, 3.

The dose increases gradually because GLP-1 medicines can slow gastric emptying and change hunger signaling. That is part of why they can help with appetite regulation, but it is also why nausea, fullness, vomiting, diarrhea, constipation, and abdominal discomfort can appear during dose increases 1.

What doses does the Wegovy pen come in?

Wegovy pens come in fixed dose strengths, so patients do not dial a custom amount on the pen. The common dose strengths used in the labeled escalation schedule are 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg once weekly 1.

In the United States, the Wegovy pen is a single-use, prefilled injection pen. That differs from some adjustable-dose injection pens used for other medications, where a patient may turn a dose selector. With Wegovy’s fixed-dose pen, each pen contains one prescribed dose strength 1, 8.

Because each strength is a different product, each step often requires a new prescription or refill plan. Manufacturer prescribing materials also describe Wegovy HD 7.2 mg for certain patients who tolerate 2.4 mg and need further weight reduction, but patients should follow the current FDA label and their prescriber’s directions because labeling and availability can change 7.

How often do you use the Wegovy pen?

Wegovy injection is labeled for once-weekly use. It can be administered on the same day each week, with or without food, according to the FDA label 1.

A consistent weekly day helps patients and care teams track doses, side effects, and refills. The label allows the day of weekly administration to be changed if the time between two doses is at least 48 hours, but this is still best handled with prescriber guidance 1.

For a broader overview of how GLP-1 schedules differ across medications, see our guide to GLP-1 dosage for weight loss.

What is the Wegovy maintenance dose?

Wegovy maintenance dosing is usually 2.4 mg once weekly when tolerated. The FDA label also allows 1.7 mg once weekly as a maintenance dose for some patients when a lower tolerated dose is appropriate 1.

Maintenance matters because obesity is often a chronic condition. In STEP 4, adults who continued once-weekly semaglutide after a run-in period maintained and extended weight loss better than those switched to placebo, while side effects and discontinuation still required monitoring; individual results vary 2.

In the STEP 1 extension, participants regained a substantial share of lost weight after semaglutide withdrawal, which supports the idea that ongoing care is often needed rather than a short medication course 3. This does not mean every person should stay on medication forever; it means the plan should be reviewed with a clinician over time.

What should patients know before increasing a Wegovy dose?

Before a Wegovy dose increase, clinicians look at side effects, weight response, hydration, eating tolerance, other medications, and contraindications. The key safety point is that faster is not automatically better 1.

The most common side effects in Wegovy labeling include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, abdominal bloating, belching, low blood sugar in people with type 2 diabetes, gas, gastroenteritis, and reflux symptoms 1. These effects are one reason many prescribers slow titration or pause at a tolerated dose.

Important warnings and contraindications include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, serious hypersensitivity to semaglutide or product components, pancreatitis, gallbladder disease, acute kidney injury risk related to dehydration, diabetic retinopathy complications in patients with type 2 diabetes, increased heart rate, and hypoglycemia risk when used with insulin or insulin secretagogues 1.

In STEP 8, once-weekly semaglutide produced greater mean weight loss than daily liraglutide in adults with overweight or obesity without diabetes, but gastrointestinal events were also common and some participants stopped treatment because of adverse events 4. STEP 6 also found weight reduction in an East Asian population with overweight or obesity, with or without type 2 diabetes, again with tolerability monitoring needed 5.

What if you miss a Wegovy pen dose?

The Wegovy missed-dose instructions depend on how close the next weekly dose is. The FDA label gives specific timing rules based on whether the next scheduled dose is more than 2 days away 1.

Per the label, if one dose is missed and the next scheduled dose is more than 2 days away, the missed dose may be administered as soon as possible. If the next scheduled dose is less than 2 days away, the missed dose is skipped and the regular schedule resumes 1.

The label also says that if more than 2 consecutive doses are missed, patients may resume as scheduled or, if needed, reinitiate and follow the dose-escalation schedule to reduce gastrointestinal symptoms 1. Patients should not double up without prescriber guidance.

How do you use and store the Wegovy pen safely?

Wegovy pen use should follow the Medication Guide and Instructions for Use each time. The label lists the abdomen, thigh, or upper arm as injection sites, and the pen is used for a subcutaneous injection, meaning under the skin 1, 8.

• Review the official Instructions for Use before using a new pen strength; the pen is fixed-dose and single-use 8.
• Use a sharps disposal container for used pens; do not place loose used pens in household trash or recycling 8.
• Store Wegovy in the refrigerator before use and protect it from light, following the label’s temperature and handling instructions 1.
• For travel, ask the pharmacist or prescriber how to keep the medication within labeled temperature limits 1.

If a pen looks damaged, has been frozen, has been exposed to temperatures outside the labeled range, or the solution looks abnormal, the safest next step is to contact the pharmacist or prescribing clinician rather than guessing.

How does Wegovy pen dosage compare with compounded semaglutide at Chia?

Wegovy is brand-name FDA-approved semaglutide; compounded semaglutide is a prescription compounded formulation that is not FDA-approved. At Chia, we do not offer Wegovy pens, but we do offer compounded semaglutide injection from licensed 503A compounding pharmacies when clinically appropriate after online review.

This distinction matters. Clinical trial results belong to the active ingredient semaglutide as studied in those trials, not to every compounded formulation. Compounded semaglutide outcomes are not evaluated by FDA, and dosing is provider-guided rather than copied from a brand pen schedule.

Chia’s process is 100% online: a short health questionnaire, review by a licensed US provider, prescribing only when clinically appropriate, and home delivery from a state-licensed 503A compounding pharmacy. Patients can message their care team through the patient portal between visits. For safety checks to consider before starting online care, see our guides to online semaglutide providers and online compounding pharmacy semaglutide.

How does Wegovy compare with Ozempic or other GLP-1 options?

Wegovy and Ozempic both contain semaglutide, but they have different FDA-approved uses and labeled dose goals. The key comparison is not just the molecule; it is the indication, dose range, device, and prescriber’s treatment goal 1.

If cost is part of the decision, compare total monthly cost, clinician access, refill timing, pharmacy standards, and whether lab or follow-up support is included. Our guides to best price for compounded semaglutide and lowest semaglutide price walk through those questions.

When should you contact a clinician about Wegovy dosage?

Contact a clinician promptly if side effects are severe, if vomiting or diarrhea makes hydration difficult, or if pain suggests pancreatitis or gallbladder disease. Wegovy labeling includes warnings for pancreatitis, gallbladder disease, kidney injury related to dehydration, hypoglycemia risk with insulin or insulin secretagogues, serious hypersensitivity, and suicidal behavior or thinking 1.

Also contact the prescriber before planned pregnancy, during pregnancy, while breastfeeding, after a major medication change, or after repeated missed doses. A safe plan depends on the whole picture, not only the dose number.

Keep reading

Weight Loss

Semaglutide Cost in Ontario: Ozempic, Wegovy, Generics, and Online Options

Weight Management

Wegovy Dosing Chart: Starting, Increasing, and Maintenance Doses

Weight Loss

Can You Order Retatrutide Online? What Patients Should Know